Table 3.
Questionnaire scores at 10 years among all responders, and by original ECLIPSE trial allocations
| All responders, mean (SD) n | Allocated to LNG-IUS, mean (SD) n | Allocated to usual medical treatment, mean (SD) n | |
|---|---|---|---|
| SF-36 | |||
| Physical functioning | 80.2 (26.2) 205 | 81.4 (24.9) 110 | 78.8 (27.7) 95 |
| Physical role | 78.4 (28.6) 204 | 80.1 (26.2) 109 | 76.4 (31.1) 95 |
| Emotional role | 79.4 (27.5) 204) | 79.3 (26.4) 109 | 79.5 (28.9) 95 |
| Social functioning | 74.7 (25.8) 206 | 75.5 (25.2) 110 | 73.8 (26.6) 96 |
| Mental health | 68.6 (21.5) 205 | 68.1 (21.1) 110 | 69.2 (22.0) 95 |
| Energy and vitality | 48.9 (10.2) 205 | 48.3 (8.8) 110 | 49.5 (11.6) 95 |
| Pain | 63.4 (24.8) 206 | 64.3 (23.9) 110 | 62.4 (25.9) 96 |
| Perception of general health | 55.4 (9.6) 206 | 55.9 (10.3) 110 | 54.9 (8.7) 95 |
|
| |||
| EuroQoL EQ-5D | |||
| Descriptive system | 0.748 (0.266) 204 | 0.757 (0.249) 110 | 0.736 (0.286) 94 |
| Visual analogue scale | 73.4 (20.7) 176 | 74.9 (19.8) 93 | 71.8 (21.6) 83 |
|
| |||
| Sexual Activity Questionnaire | |||
| Pleasure | 11.2 (4.6) 116 | 11.5 (4.6) 62 | 10.9 (4.6) 54 |
| Discomfort | 2.01 (1.99) 116 | 2.19 (2.09) 62 | 1.80 (1.87) 54 |
LNG-IUS = levonorgestrel-releasing intrauterine system. SD = standard deviation. SF-36 = 36-item Short-Form Health Survey.